Biomarin Pharmaceutical (BMRN) Deferred Taxes (2010 - 2026)
Biomarin Pharmaceutical (BMRN) posted Deferred Taxes of $9.2 million for Q1 2026, up 1404.08% on a QoQ basis from $613000.0 in Q4 2025, and down 67.57% year-over-year from $28.4 million in Q1 2025.
Biomarin Pharmaceutical (BMRN) Deferred Taxes (2010 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Deferred Taxes history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- Quarterly Deferred Taxes fell 67.57% year-over-year to $9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.5 million (down 64.95% YoY) and the FY2025 annual result came in at $48.7 million, down 13.12% from the prior year.
- Deferred Taxes was $9.2 million for Q1 2026 at Biomarin Pharmaceutical, up from $613000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $42.4 million in Q4 2024 and bottomed at -$51.3 million in Q4 2022.
- A 5-year average of $999176.5 and a median of $613000.0 in 2025 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes tumbled 1330.99% — and 2025, when it surged 9875.09%.
- Biomarin Pharmaceutical's Deferred Taxes stood at -$51.3 million in 2022, then surged by 51.61% to -$24.8 million in 2023, then jumped by 270.61% to $42.4 million in 2024, then sank by 98.55% to $613000.0 in 2025, then jumped by 1404.08% to $9.2 million in 2026.
- Business Quant data shows BMRN's Deferred Taxes at $9.2 million in Q1 2026, $613000.0 in Q4 2025, and -$13.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.22 Mn |
| Dec 31, 2025 | 613,000.00 |
| Sep 30, 2025 | -13.65 Mn |
| Jun 30, 2025 | 33.34 Mn |
| Mar 31, 2025 | 28.43 Mn |
| Dec 31, 2024 | 42.39 Mn |
| Sep 30, 2024 | 12.17 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 285,000.00 |
| Dec 31, 2023 | -24.84 Mn |
| Sep 30, 2023 | -15.03 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | -6.36 Mn |
| Dec 31, 2022 | -51.34 Mn |
| Sep 30, 2022 | -4.20 Mn |
| Jun 30, 2022 | -1.35 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | -3.59 Mn |
| Sep 30, 2021 | -13.22 Mn |
| Jun 30, 2021 | -2.13 Mn |